FDA advisory panel to discuss makeup of updated COVID shots

by
Contributor since / Followers

2 months ago

The U.S. FDA’s Vaccines and Related Biological Products Advisory Committee will meet on May 22 to discuss the formula for COVID-19 vaccines that will be used for the 2025-26 season.
mRNA vaccines from Moderna (NASDAQ:MRNA) and Pfizer (

Tags: BNTX